All Year General Virology and Serology Surveillance
Since the early 1990s, Oxford-RCGP RSC network practices have volunteered to take part in yearly influenza virology surveillance, in collaboration with Public Health England (PHE). These practices collect nasopharyngeal samples from patients clinically suspected of having influenza. Results are then linked to pseudonymised clinical data. Its primary role is to confirm cases of influenza, but also to look at the impact of other diseases, to characterise more vulnerable populations, and to support in the evaluation of vaccine effectiveness. Most interest is currently on how age, gender, ethnicity, household size, and population density link to rates of infection.
New! Since 2020, this has expanded to include year-round testing for COVID-19, as well as, a serological surveillance arm, which contributes important and timely data on background population immunity to COVID-19, and vaccine effectiveness.
Details of the expanded seasonal influenza and COVID-19 surveillance are available at: https://preprints.jmir.org/preprint/24341
To monitor the spread of respiratory viruses (including influenza, COVID-19, RSV) and measure the effectiveness of influenza vaccinations through the winter season.
New! For further details, please also see the 54th year of RCGP RSC-PHE Surveillance & Vaccine Effectiveness. This letter is to thank practices for participating in the Oxford-RCGP RSC, in partnership with PHE.
To assess background population immunity to COVID-19.
Promoting at Practice
We warmly invite practices to promote surveillance activities to patients at the practice level. If you are willing to put up a flyer, or add a research banner to your practice webpage, please contact: firstname.lastname@example.org